161 related articles for article (PubMed ID: 17237154)
1. Identification and functional assessment of BCRP polymorphisms in a Korean population.
Lee SS; Jeong HE; Yi JM; Jung HJ; Jang JE; Kim EY; Lee SJ; Shin JG
Drug Metab Dispos; 2007 Apr; 35(4):623-32. PubMed ID: 17237154
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of SNPs variants of BCRP/ABCG2.
Kondo C; Suzuki H; Itoda M; Ozawa S; Sawada J; Kobayashi D; Ieiri I; Mine K; Ohtsubo K; Sugiyama Y
Pharm Res; 2004 Oct; 21(10):1895-903. PubMed ID: 15553238
[TBL] [Abstract][Full Text] [Related]
3. Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.
Tamura A; Wakabayashi K; Onishi Y; Takeda M; Ikegami Y; Sawada S; Tsuji M; Matsuda Y; Ishikawa T
Cancer Sci; 2007 Feb; 98(2):231-9. PubMed ID: 17297656
[TBL] [Abstract][Full Text] [Related]
4. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.
Zamber CP; Lamba JK; Yasuda K; Farnum J; Thummel K; Schuetz JD; Schuetz EG
Pharmacogenetics; 2003 Jan; 13(1):19-28. PubMed ID: 12544509
[TBL] [Abstract][Full Text] [Related]
5. Ethnic differences in ATP-binding cassette transporter, sub-family G, member 2 (ABCG2/BCRP): genotype combinations and estimated functions.
Sakiyama M; Matsuo H; Takada Y; Nakamura T; Nakayama A; Takada T; Kitajiri S; Wakai K; Suzuki H; Shinomiya N
Drug Metab Pharmacokinet; 2014; 29(6):490-2. PubMed ID: 24869748
[TBL] [Abstract][Full Text] [Related]
6. Interactions of cyclosporin a with breast cancer resistance protein.
Xia CQ; Liu N; Miwa GT; Gan LS
Drug Metab Dispos; 2007 Apr; 35(4):576-82. PubMed ID: 17220244
[TBL] [Abstract][Full Text] [Related]
7. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta.
Kobayashi D; Ieiri I; Hirota T; Takane H; Maegawa S; Kigawa J; Suzuki H; Nanba E; Oshimura M; Terakawa N; Otsubo K; Mine K; Sugiyama Y
Drug Metab Dispos; 2005 Jan; 33(1):94-101. PubMed ID: 15475413
[TBL] [Abstract][Full Text] [Related]
8. ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations.
Kim KA; Joo HJ; Park JY
J Clin Pharm Ther; 2010 Dec; 35(6):705-12. PubMed ID: 21054463
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism.
Pollex EK; Anger G; Hutson J; Koren G; Piquette-Miller M
Drug Metab Dispos; 2010 May; 38(5):740-4. PubMed ID: 20159988
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
Mizuarai S; Aozasa N; Kotani H
Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics.
Sugimoto Y; Tsukahara S; Ishikawa E; Mitsuhashi J
Cancer Sci; 2005 Aug; 96(8):457-65. PubMed ID: 16108826
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphisms of the ABCG2 gene are associated with gout disease in the Chinese Han male population.
Zhou D; Liu Y; Zhang X; Gu X; Wang H; Luo X; Zhang J; Zou H; Guan M
Int J Mol Sci; 2014 May; 15(5):9149-59. PubMed ID: 24857923
[TBL] [Abstract][Full Text] [Related]
13. Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms.
Poonkuzhali B; Lamba J; Strom S; Sparreboom A; Thummel K; Watkins P; Schuetz E
Drug Metab Dispos; 2008 Apr; 36(4):780-95. PubMed ID: 18180275
[TBL] [Abstract][Full Text] [Related]
14. Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance protein.
Fujita Y; Noguchi K; Suzuki T; Katayama K; Sugimoto Y
BMC Res Notes; 2013 Nov; 6():445. PubMed ID: 24196382
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe.
Urquhart BL; Ware JA; Tirona RG; Ho RH; Leake BF; Schwarz UI; Zaher H; Palandra J; Gregor JC; Dresser GK; Kim RB
Pharmacogenet Genomics; 2008 May; 18(5):439-48. PubMed ID: 18408567
[TBL] [Abstract][Full Text] [Related]
16. Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport.
Tamura A; Watanabe M; Saito H; Nakagawa H; Kamachi T; Okura I; Ishikawa T
Mol Pharmacol; 2006 Jul; 70(1):287-96. PubMed ID: 16608919
[TBL] [Abstract][Full Text] [Related]
17. Interindividual Regulation of the Breast Cancer Resistance Protein/
Bircsak KM; Moscovitz JE; Wen X; Archer F; Yuen PYS; Mohammed M; Memon N; Weinberger BI; Saba LM; Vetrano AM; Aleksunes LM
Drug Metab Dispos; 2018 May; 46(5):619-627. PubMed ID: 29386232
[TBL] [Abstract][Full Text] [Related]
18. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.
Imai Y; Nakane M; Kage K; Tsukahara S; Ishikawa E; Tsuruo T; Miki Y; Sugimoto Y
Mol Cancer Ther; 2002 Jun; 1(8):611-6. PubMed ID: 12479221
[TBL] [Abstract][Full Text] [Related]
19. Gefitinib reverses breast cancer resistance protein-mediated drug resistance.
Yanase K; Tsukahara S; Asada S; Ishikawa E; Imai Y; Sugimoto Y
Mol Cancer Ther; 2004 Sep; 3(9):1119-25. PubMed ID: 15367706
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of ABCG2 and SLC2A9 gene polymorphisms in gouty arthritis in a Korean population.
Kim YS; Kim Y; Park G; Kim SK; Choe JY; Park BL; Kim HS
Korean J Intern Med; 2015 Nov; 30(6):913-20. PubMed ID: 26552468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
